Beleave Investor Dashboard

Company Overview:

Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets.  Beleave is fully-licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives. Beleave is developing new product lines, including cannabis-infused powder and sugar products for 2019 as the recreational market is expected to allow for food and beverage-based cannabis products.  Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi- Green banner. Through its majority ownership of Procannmed S.A.S., Beleave is fully licensed to cultivate, produce, and extract medical cannabis in Colombia positioning it to capitalize on exports and the expanding Latin American market. The Company has partnered with Canymed GmbH to supply the German market with medical cannabis.

[stock_market_chart symbol=”BE.CN” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Current Share Price#N/A
Market Capitalization (in Millions)#N/A
Last Quarter (Share Data)12/31/2018
Shares Outstanding (in Millions)474.34
Options (in Millions)38.68
Warrants (in Millions)81.66
Fully Diluted (in Millions)594.67

Enterprise Value (in Millions)#N/A
TTM Revenue$1.33
TTM Growth Margin %361.65%
TTM Operating Expenses$42.33
TTM OCF-$20.91
P/S TTM#N/A
P/S (Last Quarter Run Rate)#N/A

Key Balance Sheet Information (in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18
Cash$1.84$2.06$1.39$0.78$13.35$12.00$9.55$3.58$1.76
Biological Assets$0.66$1.27$0.51
Inventory$0.00$1.05$3.10
Total Assets$3.70$4.14$3.69$3.10$23.85$18.68$26.64$26.30$34.16
Net Tangible Assets$3.70$4.14$3.69$3.10$23.85$18.68$19.07$18.69$21.16
Intangibles/Goodwill$7.57$7.61$13.00
Total Liabilities$0.91$1.13$0.97$1.13$12.94$9.28$10.21$8.00$9.10

Key Operating Items (Quarterly in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18
Revenue$0.21$0.32$0.81
Change in Fair Value of Biologial Assets-$0.66-1.66-1.18
Gross Margin$0.871.961.99
Marketing and Sales
Investor Relations$0.07$0.52$0.13$0.11$0.37$0.75$0.81-$0.36$0.33
Total Operating Expenses$0.92$8.55$3.42$1.03$1.87$12.64$18.67$6.76$4.25
Operating Cash Flow (Quarterly)-$0.78-$0.49-$0.87-$0.83-$0.72-$3.45-$10.70-$4.50-$2.25
Investing Cash Flow (Quarterly)-$0.83-$0.17-$0.12$0.00-$2.20$0.64-$2.25-$2.26-$2.54
Financing Cash Flow (Quarterly)$3.21$0.88$0.33$0.22$15.49$1.47$10.50$0.79$3.00

Listing Statement

All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.

Share
Tweet
Share